Advanced in Stroke

Jochen C. Wohrle

Albert Einstein Allee 23, 
Ulm, BW, DE 
Advanced in Stroke
Albert Einstein Allee 23, 
Ulm, BW, DE 
OverviewLocationsClinical Research

Overview

Jochen Wohrle practices in Ulm, Germany. Mr. Wohrle is rated as an Advanced expert by MediFind in the treatment of Stroke. His top areas of expertise are Aortic Regurgitation, Coronary Heart Disease, Heart Attack, Angioplasty, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 184 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 23 articles in the study of Stroke.

Gender
Male

Locations

Albert Einstein Allee 23, Ulm, BW 89081, Germany
Other Locations
Albert Einstein Allee 23, Ulm, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
Enrollment Status: Completed
Publish Date: June 07, 2024
Intervention Type: Device
Study Phase: Phase 4
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: October 30, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drugs: Ticagrelor, Prasugrel
Study Phase: Phase 4
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
Coronary and Structural Interventions - Transcatheter Aortic Valve Replacement
Coronary and Structural Interventions - Transcatheter Aortic Valve Replacement
Enrollment Status: Completed
Publish Date: April 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions
Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions
Enrollment Status: Completed
Publish Date: April 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold
Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold
Enrollment Status: Completed
Publish Date: April 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

184 Total Publications

Absorb® bioresorbable scaffold in "established" versus "off-label" coronary lesions: 5-year data from the GABI-R® registry.
Absorb® bioresorbable scaffold in "established" versus "off-label" coronary lesions: 5-year data from the GABI-R® registry.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: March 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wohrle's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 7 Advanced Conditions
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile